Vestibular migraine and anxiety disorders: Comorbidity mechanisms, clinical impacts, and comprehensive management
Journal of Clinical and Basic Psychosomatics · 22.04.2026 · 026030002
DOI: 10.36922/jcbp026030002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Basic Psychosomatics, online erschienen am 22.04.2026. Verfasst von Daopei Zhang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The comorbidity rate of vestibular migraine in individuals with anxiety disorders is as high as 30–50%, which is significantly higher than that in the general population. The shared mechanisms are centered on abnormalities in the 5-hydroxytryptamine system and vestibular–trigeminal–limbic system interactions. This comorbidity leads to symptom exacerbation, treatment difficulty, and decreased quality of life. Treatment should target vestibular migraine and anxiety, with comprehensive interventions that combine medications and non-pharmacological approaches, with an emphasis on multidisciplinary collaboration.
Zitieren
APA
Zhang, D., Zhang, H., & Zhao, M. (2026). Vestibular migraine and anxiety disorders: Comorbidity mechanisms, clinical impacts, and comprehensive management. Journal of Clinical and Basic Psychosomatics, 0(0), 026030002. https://doi.org/10.36922/jcbp026030002
Vancouver
Zhang D, Zhang H, Zhao M. Vestibular migraine and anxiety disorders: Comorbidity mechanisms, clinical impacts, and comprehensive management. Journal of Clinical and Basic Psychosomatics. 2026;0(0):026030002. doi:10.36922/jcbp026030002
BibTeX
@article{Zhang2026,
author = {Zhang, Daopei and Zhang, Huailiang and Zhao, Min},
title = {Vestibular migraine and anxiety disorders: Comorbidity mechanisms, clinical impacts, and comprehensive management},
journal = {Journal of Clinical and Basic Psychosomatics},
year = {2026},
volume = {0},
number = {0},
pages = {026030002},
doi = {10.36922/jcbp026030002}
}
EUVIMED